(19)
(11) EP 1 831 256 A1

(12)

(43) Date of publication:
12.09.2007 Bulletin 2007/37

(21) Application number: 05790215.7

(22) Date of filing: 19.07.2005
(51) International Patent Classification (IPC): 
C07K 16/22(2006.01)
C07K 16/28(2006.01)
C12N 15/10(2006.01)
C07K 16/24(2006.01)
C12N 15/09(2006.01)
A61K 39/395(2006.01)
(86) International application number:
PCT/US2005/025663
(87) International publication number:
WO 2006/071280 (06.07.2006 Gazette 2006/27)
(84) Designated Contracting States:
AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU LV MC NL PL PT RO SE SI SK TR

(30) Priority: 23.12.2004 US 639657 P
23.12.2004 US 639698 P

(71) Applicant: GlycoFi, Inc.
Lebanon, New Hampshire 03766 (US)

(72) Inventors:
  • GERNGROSS, Tillman, U.
    Hanover, NH 03755 (US)
  • LI, Huijuan
    Lebanon, NH 03766 (US)
  • WILDT, Stefan
    Lebanon, NH 03766 (US)

(74) Representative: Horgan, James Michael Frederic et al
Merck & Co., Inc. European Patent Department Hertford Road
Hoddesdon Hertfordshire EN11 9BU
Hoddesdon Hertfordshire EN11 9BU (GB)

   


(54) IMMUNOGLOBULINS COMPRISING PREDOMINANTLY A GALGLCNACMAN5GLCNAC2 GLYCOFORM